Bridget  O'Rourke net worth and biography

Bridget O'Rourke Biography and Net Worth

Director of Penumbra
Bridget O’Rourke has served on the Board since April 2017. Ms. O’Rourke has held a number of executive and leadership positions over more than twenty years, with expertise across different industries. Most recently, Ms. O’Rourke served as Executive Director of the executive search and consulting practice of O’Rourke & Associates, a boutique firm providing services exclusively for the credit union industry, until May 2017. From August 2008 to June 2016, Ms. O’Rourke was Head of Human Resources at Passport Capital, LLC, a global asset management firm. Prior to Passport Capital, LLC, from 1997 to 2007 Ms. O’Rourke served in various positions in the financial services and executive search industries, including as Executive Search Director at O’Rourke Career Connections, Controller at Sigma Partners, a multi-fund venture capital firm, and Vice President for Citibank Global Asset Management’s Alternative Investment Strategies group. From July 1991 to December 1996, Ms. O’Rourke held audit and internal audit consulting positions of increasing responsibility at Coopers & Lybrand (now known as PricewaterhouseCoopers). Ms. O’Rourke received a B.A. from the University of California, Santa Barbara and became a Certified Public Accountant in 1995. She currently serves on the Board of Directors of the San Francisco Fire Credit Union.

What is Bridget O'Rourke's net worth?

The estimated net worth of Bridget O'Rourke is at least $958,685.00 as of November 30th, 2023. Ms. O'Rourke owns 4,214 shares of Penumbra stock worth more than $958,685 as of March 28th. This net worth approximation does not reflect any other investments that Ms. O'Rourke may own. Learn More about Bridget O'Rourke's net worth.

How do I contact Bridget O'Rourke?

The corporate mailing address for Ms. O'Rourke and other Penumbra executives is One Penumbra Place, Alameda CA, 94502. Penumbra can also be reached via phone at (510) 748-3200 and via email at [email protected]. Learn More on Bridget O'Rourke's contact information.

Has Bridget O'Rourke been buying or selling shares of Penumbra?

Bridget O'Rourke has not been actively trading shares of Penumbra during the last ninety days. Most recently, Bridget O'rourke sold 150 shares of the business's stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $226.41, for a transaction totalling $33,961.50. Following the completion of the sale, the director now directly owns 4,214 shares of the company's stock, valued at $954,091.74. Learn More on Bridget O'Rourke's trading history.

Who are Penumbra's active insiders?

Penumbra's insider roster includes Arani Bose (Insider), Adam Elsesser (CEO), Harpreet Grewal (Director), Don Kassing (Director), Bridget O'Rourke (Director), James Pray (Insider), Johanna Roberts (EVP), Surbhi Sarna (Director), and Thomas Wilder (Director). Learn More on Penumbra's active insiders.

Are insiders buying or selling shares of Penumbra?

In the last twelve months, insiders at the sold shares 28 times. They sold a total of 86,209 shares worth more than $24,304,275.51. The most recent insider tranaction occured on March, 4th when Director Arani Bose sold 7,500 shares worth more than $1,876,500.00. Insiders at Penumbra own 5.3% of the company. Learn More about insider trades at Penumbra.

Information on this page was last updated on 3/4/2024.

Bridget O'Rourke Insider Trading History at Penumbra

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2023Sell150$226.41$33,961.504,214View SEC Filing Icon  
8/1/2022Sell88$137.12$12,066.563,872View SEC Filing Icon  
7/27/2022Sell88$135.00$11,880.003,960View SEC Filing Icon  
11/15/2021Sell65$265.36$17,248.40View SEC Filing Icon  
10/14/2021Sell65$266.43$17,317.95View SEC Filing Icon  
8/16/2021Sell65$255.60$16,614.00View SEC Filing Icon  
7/14/2021Sell65$266.45$17,319.25View SEC Filing Icon  
12/14/2020Sell65$190.88$12,407.20View SEC Filing Icon  
11/13/2020Sell65$271.46$17,644.90View SEC Filing Icon  
10/13/2020Sell65$207.58$13,492.70View SEC Filing Icon  
9/14/2020Sell65$200.97$13,063.05View SEC Filing Icon  
8/13/2020Sell65$237.16$15,415.403,323View SEC Filing Icon  
7/17/2020Sell46$189.23$8,704.58View SEC Filing Icon  
4/6/2020Sell44$162.56$7,152.64View SEC Filing Icon  
1/27/2020Sell163$172.50$28,117.50View SEC Filing Icon  
7/1/2019Sell175$160.67$28,117.25View SEC Filing Icon  
4/1/2019Sell175$145.72$25,501.00View SEC Filing Icon  
12/3/2018Sell1,200$142.19$170,628.00View SEC Filing Icon  
5/25/2018Buy700$156.40$109,480.00View SEC Filing Icon  
11/21/2017Sell429$106.60$45,731.40View SEC Filing Icon  
See Full Table

Bridget O'Rourke Buying and Selling Activity at Penumbra

This chart shows Bridget O'rourke's buying and selling at Penumbra by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Penumbra Company Overview

Penumbra logo
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Read More

Today's Range

Now: $223.86
Low: $223.46
High: $228.43

50 Day Range

MA: $248.78
Low: $220.06
High: $273.27

2 Week Range

Now: $223.86
Low: $180.93
High: $348.67

Volume

257,619 shs

Average Volume

355,522 shs

Market Capitalization

$8.66 billion

P/E Ratio

96.91

Dividend Yield

N/A

Beta

0.52